Search

Neil Abrams

Examiner (ID: 5377, Phone: (571)272-2089 , Office: P/2831 )

Most Active Art Unit
3202
Art Unit(s)
2831, 2832, 2833, 1611, 2834, 3205, 2839, 3202
Total Applications
3723
Issued Applications
3063
Pending Applications
142
Abandoned Applications
516

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17369836 [patent_doc_number] => 20220024888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => CRYSTALLINE PPAR-DELTA AGONIST [patent_app_type] => utility [patent_app_number] => 17/381005 [patent_app_country] => US [patent_app_date] => 2021-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20307 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381005 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/381005
Crystalline PPAR-delta agonist Jul 19, 2021 Issued
Array ( [id] => 17342127 [patent_doc_number] => 20220008458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE [patent_app_type] => utility [patent_app_number] => 17/365695 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365695 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/365695
Trace element compositions, methods of making and use Jun 30, 2021 Issued
Array ( [id] => 17168759 [patent_doc_number] => 20210322429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => STABILIZED FORMULATIONS OF CNS COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/358920 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8158 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358920 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/358920
STABILIZED FORMULATIONS OF CNS COMPOUNDS Jun 24, 2021 Pending
Array ( [id] => 19011672 [patent_doc_number] => 11918573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Ophthalmic formulations of cetirizine and methods of use [patent_app_type] => utility [patent_app_number] => 17/332814 [patent_app_country] => US [patent_app_date] => 2021-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19581 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332814 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/332814
Ophthalmic formulations of cetirizine and methods of use May 26, 2021 Issued
Array ( [id] => 17095522 [patent_doc_number] => 20210283313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE [patent_app_type] => utility [patent_app_number] => 17/331543 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9852 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331543 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/331543
HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE May 25, 2021 Pending
Array ( [id] => 17472522 [patent_doc_number] => 20220080026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/246086 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246086 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/246086
FORMULATIONS Apr 29, 2021 Abandoned
Array ( [id] => 17020913 [patent_doc_number] => 20210244784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATE WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION [patent_app_type] => utility [patent_app_number] => 17/242115 [patent_app_country] => US [patent_app_date] => 2021-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8931 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242115 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/242115
COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATE WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION Apr 26, 2021 Abandoned
Array ( [id] => 16990122 [patent_doc_number] => 20210228542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => COMPOSITION AND METHOD FOR RAPIDLY INDUCING AN ENDOGENOUS KETOSIS [patent_app_type] => utility [patent_app_number] => 17/233007 [patent_app_country] => US [patent_app_date] => 2021-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17871 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233007 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/233007
Composition and method for rapidly inducing an endogenous ketosis Apr 15, 2021 Issued
Array ( [id] => 17546543 [patent_doc_number] => 20220117884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => Methods and Compostitions for Enhancing the Viability of Microneedle Pores [patent_app_type] => utility [patent_app_number] => 17/228941 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228941 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/228941
Methods and Compostitions for Enhancing the Viability of Microneedle Pores Apr 12, 2021 Abandoned
Array ( [id] => 16976055 [patent_doc_number] => 20210220292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/226134 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226134 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/226134
CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODS Apr 8, 2021 Abandoned
Array ( [id] => 17609655 [patent_doc_number] => 20220151934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => RAPIDLY INFUSING PLATFORM AND COMPOSITIONS FOR THERAPEUTIC TREATMENT IN HUMANS [patent_app_type] => utility [patent_app_number] => 17/225738 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225738 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/225738
Rapidly infusing platform and compositions for therapeutic treatment in humans Apr 7, 2021 Issued
Array ( [id] => 17213090 [patent_doc_number] => 20210346426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => COMPOSITION AND METHOD FOR THE TREATMENT OF COVID-19 [patent_app_type] => utility [patent_app_number] => 17/225053 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7271 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225053 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/225053
COMPOSITION AND METHOD FOR THE TREATMENT OF COVID-19 Apr 6, 2021 Abandoned
Array ( [id] => 17911336 [patent_doc_number] => 20220313731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => METHOD OF TREATING ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 17/214377 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15891 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214377 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/214377
METHOD OF TREATING ALZHEIMER'S DISEASE Mar 25, 2021 Pending
Array ( [id] => 17472372 [patent_doc_number] => 20220079876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/210719 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210719 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210719
OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR Mar 23, 2021 Abandoned
Array ( [id] => 18636384 [patent_doc_number] => 11760971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-19 [patent_title] => Modified biological control agents and their uses [patent_app_type] => utility [patent_app_number] => 17/206484 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12069 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206484
Modified biological control agents and their uses Mar 18, 2021 Issued
Array ( [id] => 17368235 [patent_doc_number] => 20220023287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => TREATMENT OF HEPATITIS DELTA VIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 17/197687 [patent_app_country] => US [patent_app_date] => 2021-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12299 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17197687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/197687
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION Mar 9, 2021 Abandoned
Array ( [id] => 16998450 [patent_doc_number] => 11077232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-03 [patent_title] => Methods and polymer compositions for treating retinal detachment and other ocular disorders [patent_app_type] => utility [patent_app_number] => 17/191942 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16093 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191942 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/191942
Methods and polymer compositions for treating retinal detachment and other ocular disorders Mar 3, 2021 Issued
Array ( [id] => 17355336 [patent_doc_number] => 20220016132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES [patent_app_type] => utility [patent_app_number] => 17/181781 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181781 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/181781
BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES Feb 21, 2021 Pending
Array ( [id] => 17035092 [patent_doc_number] => 20210252050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => ANTI-INFLAMMATORY, DISINFECTING AND ACCELERATED HEALING GEL FOR WOUNDS AND LESIONS [patent_app_type] => utility [patent_app_number] => 17/155748 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4975 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155748 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/155748
ANTI-INFLAMMATORY, DISINFECTING AND ACCELERATED HEALING GEL FOR WOUNDS AND LESIONS Jan 21, 2021 Abandoned
Array ( [id] => 16776434 [patent_doc_number] => 20210113511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE [patent_app_type] => utility [patent_app_number] => 17/137883 [patent_app_country] => US [patent_app_date] => 2020-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137883 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/137883
METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE Dec 29, 2020 Pending
Menu